CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,564 | -37.0% | 2,854 | 0.0% | 0.00% | – |
| Q2 2023 | $10,417 | -13.2% | 2,854 | +16.5% | 0.00% | – |
| Q1 2022 | $12,000 | -57.1% | 2,450 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $28,000 | -22.2% | 2,450 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | +24.1% | 2,450 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $29,000 | -3.3% | 2,450 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | -3.2% | 2,450 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $31,000 | -16.2% | 2,450 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $37,000 | -38.3% | 2,450 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $60,000 | +172.7% | 2,450 | +55.5% | 0.00% | +200.0% |
| Q1 2020 | $22,000 | -12.0% | 1,576 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $25,000 | +92.3% | 1,576 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | -7.1% | 1,576 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +16.7% | 1,576 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | +71.4% | 1,576 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -50.0% | 1,576 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $14,000 | -26.3% | 1,576 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $19,000 | +72.7% | 1,576 | +109.6% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | – | 752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |